Quest Diagnostics Incorporated – Consensus Indicates Potential 3.0% Upside

Broker Ratings

Quest Diagnostics Incorporated with ticker code (DGX) now have 15 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 181 and 130 with a mean TP of 157.67. Now with the previous closing price of 153.09 this indicates there is a potential upside of 3.0%. There is a 50 day moving average of 152.42 and the 200 moving average now moves to 137.11. The market capitalisation for the company is $18,312m. Company Website:

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits
You might also enjoy reading  Quest Diagnostics Incorporated - Consensus Indicates Potential 1.9% Upside

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index